Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...

Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...

Implanting a sensor in a region of the brain that helps to control speech was shown in a U.S. study to not only decode the intended speech of a man with amyotrophic lateral sclerosis (ALS), but also ...

Two things that are constantly required in life with ALS are love and patience, writes columnist. A little laughter also helps.

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) for SPG302, its oral treatment for amyotrophic lateral sclerosis (ALS).

Columnist Dagmar Munn hopes everyone will send out a mayday call during this ALS Awareness Month, to spread the urgent needs ...